Kara L. Mungovan
Lawyers
![](/sites/default/files/styles/teaser_headshot/public/lawyer-images/33486_kmungov_0.jpg?itok=pN9WFi24)
Filters
Alteryx $450 million senior notes offering
The 8.75% notes are due 2028
ADC Therapeutics secondary offering
We advised ADC Therapeutics on the registered secondary offering of its shares
Roivant Sciences $230 million stock offering
We advised the company on its SEC-registered offering
Pacific Biosciences $201.25 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Semtech $1.815 billion Sierra Wireless acquisition financing
We advised Semtech on a new term loan facility, the amendment to its revolver and its issuance of convertible notes
Sirio Pharma acquisition of a majority stake of Best Formulations
We advised Sirio Pharma on the acquisition
Save A Lot $415 million term loan and $200 million ABL facilities refinancing
We advised Moran Foods on the refinancing
Chart Industries $1.97 billion notes offering
The high-yield senior notes are due 2030 and 2031
Chart Industries $1.1 billion common and depositary share offerings
The proceeds will be used to fund in part the acquisition of Howden
Telefónica Celular del Paraguay cash tender offer
We advised TELECEL on its tender offer for its outstanding 5.875% senior notes due 2027